100
Participants
Start Date
April 21, 2025
Primary Completion Date
March 31, 2027
Study Completion Date
June 30, 2027
Buprenorphine Transdermal System
The buprenorphine transdermal system is unique from other interventions in the study, as it is the experimental drug in the study. The buprenorphine transdermal system will be applied in the pre-operative holding area. Aside from the buprenorphine transdermal system, participants assigned to this intervention will otherwise receive the standard of care in their post-operative pain management following ankle fracture surgery.
Placebo Patch
The placebo patch is unique from other interventions in the study, as it is the placebo drug in the study. The placebo patch will be applied in the pre-operative holding area. Aside from the placebo patch, participants assigned to this intervention will otherwise receive the standard of care in their post-operative pain management following ankle fracture surgery.
RECRUITING
Washington University in St. Louis/Barnes Jewish Hospital, St Louis
The Foundation for Barnes-Jewish Hospital
OTHER
Washington University Institute of Clinical and Translational Sciences
UNKNOWN
Jenna-Leigh Wilson
OTHER